Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.0010
0.0000
(0.00%)
As of 9:21:36 AM GMT+1. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Dilkes (Bradley John) Director (Non-Executive) | Conversion | Dec 28, 2023 | 52,150,000 |
| Hainsworth (David Richard) Executive Chairman | Conversion | Dec 28, 2023 | 25,625,000 |
| Latham (Bradley Roland) Director (Non-Executive) | Conversion | Dec 28, 2023 | 20,000,000 |
| Sue (Carolyn M) Director (Independent) | Acquisition | Apr 24, 2023 | 1,125,000 |
Related Tickers
DNAG DNAPrint Genomics, Inc.
0.0000
-99.00%
ARTV Artiva Biotherapeutics, Inc.
5.90
+11.11%
CYCCP Cyclacel Pharmaceuticals, Inc.
5.50
-17.42%
FOLD Amicus Therapeutics, Inc.
8.88
+2.90%
RAPP Rapport Therapeutics, Inc.
8.96
+8.34%
XCUR Exicure, Inc.
10.65
-0.47%
ALXO ALX Oncology Holdings Inc.
0.9734
+8.93%
CAPR Capricor Therapeutics, Inc.
12.58
+1.94%
DWTX Dogwood Therapeutics, Inc.
11.13
+31.87%
BTAI BioXcel Therapeutics, Inc.
2.4700
-16.84%